there has been comments on discussions with KOLs I really don’t believe too much if for trial design. The results are inline with historical and dose escalation. Instead it must be for commercialisation support to get into patients. That’s my gut feel anyway. Could be wrong. Hopefully AGM we will have clarity.
there has been comments on discussions with KOLs I really don’t...
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.87 |
Change
0.005(0.27%) |
Mkt cap ! $316.8M | |||
| Open | High | Low | Value | Volume |
| $1.86 | $1.91 | $1.85 | $48.16K | 25.65K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1161 | $1.85 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.87 | 308 | 1 |
View Market Depth
| Last trade - 13.03pm 19/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |